Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
37,449,865
-
Shares change
-
+586,056
-
Total reported value, excl. options
-
$28,947,595
-
Value change
-
+$901,306
-
Put/Call ratio
-
4.35%
-
Number of buys
-
17
-
Number of sells
-
-43
-
Price
-
$0.7732
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q3 2024
79 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q3 2024.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,449,865 shares
.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (7,167,591 shares), Avidity Partners Management LP (5,026,000 shares), TANG CAPITAL MANAGEMENT LLC (3,640,300 shares), VANGUARD GROUP INC (2,741,105 shares), Affinity Asset Advisors, LLC (2,511,778 shares), ORBIMED ADVISORS LLC (1,927,000 shares), ACADIAN ASSET MANAGEMENT LLC (1,577,123 shares), Stonepine Capital Management, LLC (1,491,305 shares), TWO SIGMA ADVISERS, LP (1,402,900 shares), and RENAISSANCE TECHNOLOGIES LLC (1,297,074 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.